ENTA Enanta Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

ENTA [NASD]

Enanta Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	45.74	EPS (ttm)	1.12	Insider Own	5.20%	Shs Outstand	19.92M	Perf Week	2.48%
Market Cap	1.05B	Forward P/E	-	EPS next Y	-2.73	Insider Trans	0.00%	Shs Float	17.66M	Perf Month	0.00%
Income	23.70M	PEG	-	EPS next Q	-0.82	Inst Own	91.30%	Short Float	9.51%	Perf Quarter	-3.51%
Sales	175.90M	P/S	5.97	EPS this Y	-39.70%	Inst Trans	-2.26%	Short Ratio	10.56	Perf Half Y	-15.17%
Book/sh	24.39	P/B	2.10	EPS next Y	-90.90%	ROA	4.80%	Target Price	72.50	Perf Year	-41.04%
Cash/sh	17.30	P/C	2.96	EPS next 5Y	-	ROE	5.00%	52W Range	38.40 - 89.25	Perf YTD	-17.16%
Dividend	-	P/FCF	30.28	EPS past 5Y	4.30%	ROI	8.10%	52W High	-42.66%	Beta	0.53
Dividend %	-	Quick Ratio	20.60	Sales past 5Y	33.90%	Gross Margin	-	52W Low	33.28%	ATR	1.97
Employees	132	Current Ratio	20.60	Sales Q/Q	-30.30%	Oper. Margin	6.40%	RSI (14)	51.68	Volatility	3.09% 4.09%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-253.30%	Profit Margin	13.50%	Rel Volume	0.72	Prev Close	51.10
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 AMC	Payout	0.00%	Avg Volume	159.01K	Price	51.18
Recom	2.70	SMA20	2.10%	SMA50	-0.23%	SMA200	-8.28%	Volume	113,945	Change	0.16%

Mar-17-20

Upgrade

Robert W. Baird

Neutral → Outperform

$60

Nov-22-19

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Sep-26-19

Downgrade

JP Morgan

Neutral → Underweight

$86 → $57

May-24-19

Initiated

Wolfe Research

Outperform

$117

Apr-23-19

Upgrade

Berenberg

Hold → Buy

$80 → $120

Dec-13-18

Initiated

Berenberg

Hold

$80

Jun-06-18

Initiated

ROTH Capital

Buy

$133

Feb-08-18

Downgrade

JP Morgan

Overweight → Neutral

Jan-02-18

Downgrade

RBC Capital Mkts

Outperform → Sector Perform

Nov-21-17

Reiterated

RBC Capital Mkts

Outperform

$54 → $58

Sep-15-17

Initiated

RBC Capital Mkts

Outperform

$54

Jul-11-17

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

Apr-28-16

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Feb-09-16

Reiterated

Barclays

Underweight

$16 → $18

Oct-23-15

Upgrade

JMP Securities

Mkt Perform → Mkt Outperform

$32

Oct-23-15

Downgrade

Barclays

Equal Weight → Underweight

$45 → $16

Aug-07-15

Reiterated

Barclays

Equal Weight

$35 → $45

Apr-06-15

Initiated

Deutsche Bank

Buy

$42

Mar-04-15

Initiated

Barclays

Equal Weight

$35

Aug-15-14

Initiated

FBR Capital

Outperform

$52

Jul-09-20 07:01AM	Enanta Pharmaceuticals Announces Clinical Trial Progress for EDP-514, its Lead Core Inhibitor for Hepatitis B Virus Business Wire
Jun-29-20 07:00AM	Enanta Pharmaceuticals Announces the Appointment of Mark G. Foletta to Its Board of Directors Business Wire
Jun-23-20 12:23PM	Hedge Funds Are Selling Enanta Pharmaceuticals Inc (ENTA) Insider Monkey
Jun-11-20 07:02AM	Enanta Pharmaceuticals to Present at the Raymond James Human Health Innovation Conference Business Wire -5.74%
Jun-04-20 10:20PM	Edited Transcript of ENTA earnings conference call or presentation 6-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-23-20 09:58AM	If You Had Bought Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Three Years Ago, You Could Pocket A 84% Gain Today Simply Wall St.
May-14-20 08:53AM	Why Enanta Pharmaceuticals (ENTA) Stock Might be a Great Pick Zacks
May-12-20 07:30AM	Enanta Pharmaceuticals to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference Business Wire
May-09-20 09:43PM	Were Hedge Funds Right About Enanta Pharmaceuticals Inc (ENTA)? Insider Monkey
May-07-20 12:01AM	Enanta Pharmaceuticals Inc (ENTA) Q2 2020 Earnings Call Transcript Motley Fool
May-06-20 06:45PM	Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:03PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2020 with Webcast and Conference Call Today at 4:30 p.m. ET Business Wire
04:03PM	Enanta Announces Results of INTREPID Study of EDP-305 for the Treatment of Primary Biliary Cholangitis Business Wire
Apr-29-20 12:34PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-28-20 04:05PM	Enanta to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Second Quarter Ended March 31, 2020 Business Wire -7.59%
12:33PM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-17-20 10:19AM	Is Enanta Pharmaceuticals (NASDAQ:ENTA) Using Too Much Debt? Simply Wall St.
Mar-26-20 04:05PM	Enanta Provides Update on Clinical Development Activities During COVID-19 Pandemic Business Wire +6.63%
Mar-13-20 07:00AM	Enanta Pharmaceuticals Announces Efforts to Discover a Treatment for the Novel Coronavirus Disease COVID-19 Business Wire +9.19%
Mar-06-20 07:05AM	Enantas HCV Collaboration Partner AbbVie Receives Marketing Authorization from European Commission to Shorten MAVIRET® (glecaprevir/pibrentasvir) Duration to Eight Weeks for Treatment-Naïve Genotype 3 HCV Patients with Compensated Cirrhosis Business Wire
Mar-04-20 08:09AM	Does Market Volatility Impact Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) Share Price? Simply Wall St.
Feb-12-20 12:18AM	Edited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-06-20 05:15PM	Enanta Pharmaceuticals (ENTA) Q1 Earnings Top Estimates Zacks
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter and Three Months Ended December 31, 2019 Business Wire
02:30PM	Enanta Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-05-20 04:11PM	13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market Benzinga
Feb-03-20 07:27AM	Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) High P/E Ratio A Problem For Investors? Simply Wall St.
Jan-30-20 12:31PM	Earnings Preview: Enanta Pharmaceuticals (ENTA) Q1 Earnings Expected to Decline Zacks
Jan-24-20 07:30AM	Enanta to Host Conference Call on February 6 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2019 Business Wire
Jan-14-20 05:30AM	AbbVie's MAVIRET® now listed on the Newfoundland and Labrador formulary CNW Group
Jan-09-20 07:30AM	Enanta to Provide Updates on its R&D Programs and Business Outlook for 2020 during the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Jan-04-20 08:44AM	Does This Valuation Of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Imply Investors Are Overpaying? Simply Wall St.
Dec-30-19 07:30AM	Enanta Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-11-19 11:25AM	Is Enanta Pharmaceuticals Inc (ENTA) A Good Stock To Buy? Insider Monkey
Dec-09-19 07:38AM	Should You Worry About Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pay Cheque? Simply Wall St.
Dec-07-19 11:24PM	Edited Transcript of ENTA earnings conference call or presentation 21-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-22-19 08:18AM	The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate Benzinga
Nov-21-19 05:15PM	Enanta Pharmaceuticals (ENTA) Lags Q4 Earnings and Revenue Estimates Zacks
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019 Business Wire
07:22AM	The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon Benzinga
Nov-17-19 08:42AM	The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down Benzinga
Nov-14-19 10:30AM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Nov-11-19 10:21AM	Is Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) 14% ROE Worse Than Average? Simply Wall St.
07:30AM	Enanta Pharmaceuticals Announces Poster Presentations at The Liver Meeting® 2019 Business Wire
Nov-05-19 04:00PM	Enanta Pharmaceuticals to Host Conference Call on November 21 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019 Business Wire
Oct-27-19 10:29PM	Enanta Pharmaceuticals Inc (ENTA): Hedge Funds In Wait-and-See Mode Insider Monkey
Oct-21-19 04:00PM	Enanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare Conference Business Wire
Oct-12-19 10:03AM	Is Enanta Pharmaceuticals's (NASDAQ:ENTA) Share Price Gain Of 145% Well Earned? Simply Wall St.
Oct-03-19 07:30AM	New Data from Enantas Phase 2a Human Challenge Study of EDP-938 for RSV Demonstrates Highly Statistically Significant Reductions (p<0.001) in Total Symptom Score, Mucus Weight and RSV Viral Load as Measured by RT-PCR Assay and by Plaque Assay Business Wire
Sep-30-19 04:48PM	Six Mass. businesses make Fortunes list of 100 fastest-growing companies American City Business Journals
Sep-26-19 04:16PM	This Biotech Stock Just Careened Toward Its Lowest Point In Nearly 2 Years Investor's Business Daily -15.11%
11:40AM	Enanta's Stock Down Despite NASH Drug Meeting Goal in Study Zacks
07:54AM	The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J Benzinga
Sep-25-19 04:28PM	UPDATE 1-Enanta Pharma's NASH drug meets mid-stage study goal Reuters
04:12PM	Enanta Pharma's liver disease drug meets mid-stage study goal Reuters
04:00PM	Enanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASH Business Wire
Sep-12-19 09:48AM	Is Enanta Pharmaceuticals (NASDAQ:ENTA) A Risky Investment? Simply Wall St.
Sep-10-19 07:30AM	New Data from Enantas Phase 2a Human Challenge Study of EDP-938 for RSV to be Presented at IDWeek 2019 Business Wire
Aug-21-19 07:30AM	Enanta Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference Business Wire
Aug-19-19 02:54PM	Edited Transcript of ENTA earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-13-19 01:24PM	Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Aug-07-19 12:37PM	Enanta Pharmaceuticals, Inc. (ENTA) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 05:55PM	Enanta Pharmaceuticals (ENTA) Q3 Earnings Surpass Estimates Zacks
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2019 Business Wire
Aug-02-19 08:51AM	Enantas HCV Collaboration Partner AbbVie receives Approval by the European Commission for MAVIRET (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve HCV Patients with Compensated Cirrhosis Business Wire
Jul-30-19 10:38AM	Enanta Pharmaceuticals (ENTA) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Jul-15-19 07:30AM	Enanta Pharmaceuticals to Host Conference Call on August 6 at 4:30 pm ET to Discuss its Financial Results for its Fiscal Third Quarter Ended June 30, 2019 Business Wire
Jul-11-19 09:00AM	Enanta Pharmaceuticals (ENTA) Upgraded to Strong Buy: Here's What You Should Know Zacks
Jul-08-19 07:30AM	Enanta Pharmaceuticals Initiates Phase 1 Clinical Study of EDP-514, its Lead Core Inhibitor for the Treatment of Hepatitis B Virus (HBV) Business Wire
Jun-14-19 02:06PM	Enanta's Respiratory Virus Drug Aces Midstage Study Benzinga -11.85%
11:12AM	How Much Did Enanta Pharmaceuticals, Inc.'s (NASDAQ:ENTA) CEO Pocket Last Year? Simply Wall St.
09:51AM	UPDATE 1-Enanta's lung infection therapy succeeds in mid-stage trial Reuters
06:00AM	REFILE-Enanta's lung infection therapy succeeds in mid-stage trial Reuters
06:00AM	Enanta Pharmaceuticals Announces Topline Results Showing EDP-938 Achieved its Primary and Secondary Endpoints in its Phase 2a Human Challenge Study in Healthy Adults Infected with Respiratory Syncytial Virus (RSV) Business Wire
Jun-10-19 04:00PM	Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences Business Wire
08:00AM	AbbVie's MAVIRET now listed on the Nova Scotia and Manitoba formularies CNW Group
May-30-19 08:00AM	AbbVie's MAVIRET now listed in New Brunswick CNW Group
May-15-19 08:23PM	Edited Transcript of ENTA earnings conference call or presentation 7-May-19 8:30pm GMT Thomson Reuters StreetEvents
11:11AM	Do Enanta Pharmaceuticals's (NASDAQ:ENTA) Earnings Warrant Your Attention? Simply Wall St.
May-14-19 04:01PM	Enanta Pharmaceuticals to Present at Upcoming Investor Conference Business Wire
May-07-19 09:00PM	Enanta Pharmaceuticals, Inc. (ENTA) Q2 2019 Earnings Call Transcript Motley Fool
05:25PM	Enanta Pharmaceuticals (ENTA) Beats Q2 Earnings Estimates Zacks
04:16PM	Enanta Pharmaceuticals: Fiscal 2Q Earnings Snapshot Associated Press
04:00PM	Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019 Business Wire
May-02-19 02:22PM	Heres What Hedge Funds Think About Enanta Pharmaceuticals Inc (ENTA) Insider Monkey
Apr-30-19 10:32AM	Analysts Estimate Enanta Pharmaceuticals (ENTA) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-22-19 04:30PM	Enanta Pharmaceuticals to Host Conference Call on May 7th at 4:30 pm ET to Discuss Its Financial Results for Its Fiscal Second Quarter Ended March 31, 2019 Business Wire
Apr-11-19 10:13AM	Enanta Pharmaceuticals Presents New Preclinical Data on Compounds Targeting Hepatitis B Virus and Non-Alcoholic Steatohepatitis at The International Liver Congress 2019 Business Wire
09:00AM	AbbVie's MAVIRET now reimbursed in Quebec CNW Group
Apr-05-19 03:32PM	Can You Imagine How Chuffed Enanta Pharmaceuticals's (NASDAQ:ENTA) Shareholders Feel About Its 216% Share Price Gain? Simply Wall St.
Apr-04-19 10:00AM	AbbVie Announces New Formulary Listings for its Hepatitis C Treatment MAVIRET CNW Group
Apr-01-19 09:25AM	The Zacks Analyst Blog Highlights: Celgene, Puma, Exelixis, Enanta and Sage Zacks
Mar-27-19 05:24AM	Enanta Pharmaceuticals Announces Data Presentations at The International Liver Congress 2019 Business Wire
Mar-18-19 07:30AM	Enanta Pharmaceuticals Completes Enrollment in Two Ongoing Phase 2 Studies Business Wire
Mar-11-19 07:30AM	Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences Business Wire
Feb-15-19 07:35AM	Factors of Influence in 2019, Key Indicators and Opportunity within BCE, Nektar Therapeutics, Hormel Foods, Enanta Pharmaceuticals, MongoDB, and Regal Beloit New Research Emphasizes Economic Growth GlobeNewswire +6.34%
Feb-10-19 11:22PM	Edited Transcript of ENTA earnings conference call or presentation 6-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Feb-06-19 08:43PM	Enanta Pharmaceuticals Inc (ENTA) Q1 2019 Earnings Conference Call Transcript Motley Fool
05:10PM	Enanta Pharmaceuticals (ENTA) Lags Q1 Earnings and Revenue Estimates Zacks
04:07PM	Enanta Pharmaceuticals: Fiscal 1Q Earnings Snapshot Associated Press

Enanta Pharmaceuticals, Inc., a biotechnology company, focuses on the research and development of small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, non-alcoholic steatohepatitis, primary biliary cholangitis, and hepatitis B virus. Enanta Pharmaceuticals, Inc. has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MELLETT PAUL J	Treasurer and CFO	May 05	Option Exercise	1.21	1,740	2,100	42,824	May 07 05:35 PM
Gardiner Nathaniel S.	Sr. VP & General Counsel	Mar 12	Option Exercise	30.00	3,000	90,000	27,605	Mar 16 06:27 PM
MELLETT PAUL J	Treasurer and CFO	Jan 02	Sale	60.88	10,000	608,800	40,054	Jan 06 06:17 PM
Gardiner Nathaniel S.	Sr. VP & General Counsel	Nov 22	Option Exercise	31.42	1,592	50,021	19,739	Nov 25 05:01 PM
Luly Jay R.	President and CEO	Oct 08	Option Exercise	14.18	7,052	99,997	638,246	Oct 09 05:17 PM
Gardiner Nathaniel S.	Sr. VP & General Counsel	Sep 27	Option Exercise	30.00	5,000	150,000	19,871	Sep 30 04:45 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience